Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Expression of the chemokine receptor CCR6 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Minamiya Y, Saito H, Takahashi N, Ito M, Toda H, Ono T, Konno H, Motoyama S, Ogawa J.

Tumour Biol. 2011 Feb;32(1):197-202. doi: 10.1007/s13277-010-0113-x. Epub 2010 Sep 25.

PMID:
20872189
2.

Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Saito H, Minamiya Y, Watanabe H, Takahashi N, Ito M, Toda H, Konno H, Mitsui M, Motoyama S, Ogawa J.

Ann Surg Oncol. 2011 Nov;18(12):3377-83. doi: 10.1245/s10434-011-1798-9. Epub 2011 May 21.

PMID:
21603869
3.

Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Minamiya Y, Saito H, Takahashi N, Ito M, Imai K, Ono T, Motoyama S, Ogawa J.

Lung Cancer. 2010 Jun;68(3):466-71. doi: 10.1016/j.lungcan.2009.07.015. Epub 2009 Aug 27.

PMID:
19716197
4.

Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.

Zhao J, Zhao Y, Xuan Y, Jiao W, Qiu T, Wang Z, Luo Y.

Indian J Cancer. 2015 Dec;52 Suppl 2:e125-9. doi: 10.4103/0019-509X.172509.

5.

Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung.

Minamiya Y, Ono T, Saito H, Takahashi N, Ito M, Motoyama S, Ogawa J.

Tumour Biol. 2010 Oct;31(5):533-9. doi: 10.1007/s13277-010-0066-0. Epub 2010 Jun 19.

PMID:
20563766
6.

Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma.

Ishikawa M, Sonobe M, Imamura N, Sowa T, Shikuma K, Date H.

World J Surg Oncol. 2014 Aug 8;12:253. doi: 10.1186/1477-7819-12-253.

7.

ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.

Zhang Y, Sun Y, Li Y, Fang Z, Wang R, Pan Y, Hu H, Luo X, Ye T, Li H, Wang L, Chen H, Ji H.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S577-82. doi: 10.1245/s10434-013-3027-1. Epub 2013 Jun 18.

PMID:
23775406
8.

Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung.

Minamiya Y, Ono T, Saito H, Takahashi N, Ito M, Mitsui M, Motoyama S, Ogawa J.

Lung Cancer. 2011 Nov;74(2):300-4. doi: 10.1016/j.lungcan.2011.02.019. Epub 2011 Apr 5.

PMID:
21466904
9.

Acquired xanthine dehydrogenase expression shortens survival in patients with resected adenocarcinoma of lung.

Konno H, Minamiya Y, Saito H, Imai K, Kawaharada Y, Motoyama S, Ogawa J.

Tumour Biol. 2012 Oct;33(5):1727-32. doi: 10.1007/s13277-012-0431-2. Epub 2012 Jun 8.

PMID:
22678977
10.

ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.

Ni SS, Zhang J, Zhao WL, Dong XC, Wang JL.

Tumour Biol. 2013 Jun;34(3):1813-8. doi: 10.1007/s13277-013-0721-3. Epub 2013 Mar 9.

PMID:
23475633
11.

Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.

Ishikawa M, Sonobe M, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Date H.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S467-76. doi: 10.1245/s10434-012-2795-3. Epub 2012 Dec 16.

12.

Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.

Li H, Zhou RJ, Zhang GQ, Xu JP.

Tumour Biol. 2013 Jun;34(3):1807-12. doi: 10.1007/s13277-013-0720-4. Epub 2013 Mar 8.

PMID:
23471668
13.

High expression of Sonic hedgehog signaling proteins is related to the favorable outcome, EGFR mutation, and lepidic predominant subtype in primary lung adenocarcinoma.

Kim JE, Kim H, Choe JY, Sun P, Jheon S, Chung JH.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S570-6. doi: 10.1245/s10434-013-3022-6. Epub 2013 May 26. Erratum in: Ann Surg Oncol. 2013 Dec;20 Suppl 3:S755.

PMID:
23709101
14.

Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.

Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G.

Clin Transl Oncol. 2016 Apr;18(4):360-8. doi: 10.1007/s12094-015-1377-9. Epub 2015 Aug 26.

PMID:
26307752
15.

DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.

Tsai MH, Chen WC, Yu SL, Chen CC, Jao TM, Huang CY, Tzeng ST, Yen SJ, Yang YC.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1481-9. doi: 10.1245/s10434-015-4593-1. Epub 2015 May 13.

PMID:
25968618
16.

Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.

Okugawa Y, Inoue Y, Tanaka K, Toiyama Y, Shimura T, Okigami M, Kawamoto A, Hiro J, Saigusa S, Mohri Y, Uchida K, Kusunoki M.

Oncol Rep. 2013 Sep;30(3):1449-54. doi: 10.3892/or.2013.2558. Epub 2013 Jun 20.

PMID:
23784200
17.

Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.

Huang Q, Fan J, Qian X, Lv Z, Zhang X, Han J, Wu F, Chen C, Du J, Guo M, Hu G, Jin Y.

J Cancer Res Clin Oncol. 2016 Jan;142(1):263-72. doi: 10.1007/s00432-015-2040-0. Epub 2015 Aug 30.

PMID:
26319393
18.

Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.

Gill S, Haince JF, Shi Q, Pavey ES, Beaudry G, Sargent DJ, Fradet Y.

Clin Colorectal Cancer. 2015 Jun;14(2):99-105. doi: 10.1016/j.clcc.2014.12.005. Epub 2014 Dec 24.

PMID:
25619805
19.

High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.

Cortes-Dericks L, Galetta D, Spaggiari L, Schmid RA, Karoubi G.

Eur J Cardiothorac Surg. 2012 Jun;41(6):e173-81. doi: 10.1093/ejcts/ezs170. Epub 2012 Apr 23.

PMID:
22529186
20.

Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung Adenocarcinoma.

Zheng D, Wang R, Pan Y, Zheng S, Zhang Y, Li H, Cheng C, Gong R, Li Y, Shen X, Hu H, Cai D, Cheng X, Sun Y, Chen H.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1284-91. doi: 10.1245/s10434-015-4640-y. Epub 2015 Jul 23.

PMID:
26202550

Supplemental Content

Support Center